Evidence Based Hair
Evidence Based Hair
Dr Jeff Donovan
Season 8, Episode 9: Dupilumab: A Promising Treatment for Pediatric Alopecia Areata
14 minutes Posted Dec 9, 2024 at 11:02 am.
Introduction to the Podcast
Study Overview: Dupilumab for Alopecia Areata
Efficacy of Dupilumab in Children
Safety Profile of Dupilumab
Special Considerations for Pediatric Patients
Limitations and Future Research Needs
Next Week’s Topic: Upatacitinib in Treatment
Closing Remarks and Educational Opportunities
0:00
14:26
Download MP3
Show notes
Welcome to the latest episode of the Evidence-Based Hair Podcast, hosted by dermatologist and hair loss specialist Dr. Jeff Donovan. In this episode, we delve into an intriguing study titled "Dupilumab Induces Hair Regrowth in Pediatric Alopecia Areata," which explores the potential of dupilumab as a treatment for children suffering from both alopecia areata and atopic dermatitis.
Dr. Donovan discusses the study's findings, highlighting how dupilumab has shown promise in improving hair growth in this unique patient population. With a good safety profile, dupilumab emerges as a viable option alongside JAK inhibitors for managing these conditions. The episode also covers the study's methodology and results, emphasizing the significant reduction in SALT scores among the participants.
Join Dr. Donovan as he shares insights into the complexities of treating pediatric alopecia areata and the potential of dupilumab to offer new hope for patients and clinicians alike. Stay tuned for the next episode, where we'll explore the use of upadacitinib in managing dissecting cellulitis.
 
 
STUDY REFERENCED IN THIS EPISODE
Eden David, Neda Shokrian, Ester Del Duca, Marguerite Meariman, Jacob Glickman, Sabrina Ghalili, Seungyeon Jung, Kathryn Tan, Benjamin Ungar, Emma Guttman-Yassky. Dupilumab induces hair regrowth in pediatric alopecia areata: a real-world, single-center observational study. Arch Dermatol Res . 2024 Jul 23;316(7):487. doi: 10.1007/s00403-024-03225-4.